Page last updated: 2024-08-26

melanotan-ii and msh, 4-nle-7-phe-alpha-

melanotan-ii has been researched along with msh, 4-nle-7-phe-alpha- in 18 studies

Research

Studies (18)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (16.67)	18.2507
2000's	8 (44.44)	29.6817
2010's	7 (38.89)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dickinson, C; Gantz, I; Haskell-Luevano, C; Hruby, VJ; Nikiforovich, G; Sharma, SD; Yang, YK	1
Boteju, L; Castrucci, AM; Hadley, ME; Haskell-Luevano, C; Hruby, VJ; Job, C; Toth, K	1
Bauzo, RM; Haskell-Luevano, C; Holder, JR; Xiang, Z	2
Hruby, VJ	1
Bauzo, RM; Haskell-Luevano, C; Joseph, CG; Richards, NG; Scott, JW; Wang, XS; Xiang, Z	1
Edison, AS; Haskell-Luevano, C; Scott, JW; Wilczynski, A; Wilson, KR	1
Faier, A; Gabinet, Y; Gilon, C; Halbfinger, E; Haskell-Luevano, C; Hess, S; Hoffman, A; Lapidot, T; Linde, Y; Ovadia, O; Portillo, FP; Safrai, E; Shalev, DE; Swed, A; Winkler, I; Xiang, Z; Yarden, D	1
Chorev, M; D'Ursi, AM; Dirain, ML; Grimaldi, M; Haskell-Luevano, C; Lubin-Germain, N; Papini, AM; Rovero, P; Scrima, M; Singh, A; Testa, C	1
Diness, F; Gonçalves, JPL; Hald, H; Le Quement, ST; Meldal, M; Nielsen, TE; Palmer, D; Schoffelen, S; V Hansen, L; Wu, B	1
al-Obeidi, F; Blanchard, J; Dawson, BV; Dorr, RT; Hadley, ME; Hruby, VJ; Levine, N; Sawyer, TK	1
Chandler, M; Dawson, RT; Evans-Brown, M; McVeigh, J	1
Chai, B; Li, JY; Mulholland, MW; Wang, H; Zhang, W	1
Mahiques-Santos, L	1
Mäkelä, S; Rinne, P; Savontaus, E; Streng, T; Tikka, S	1
Barrett, CE; Inoue, K; Kittelberger, KA; Landgraf, R; Modi, ME; Smith, DG; Young, LJ	1
Bergman, W; Habbema, L; Halk, AB; Neumann, M	1
Callaghan Iii, DJ	1

Reviews

2 review(s) available for melanotan-ii and msh, 4-nle-7-phe-alpha-

Article	Year
Discovery and development of novel melanogenic drugs. Melanotan-I and -II. Pharmaceutical biotechnology, 1998, Volume: 11 Topics: alpha-MSH; Amino Acid Sequence; Animals; Anticarcinogenic Agents; Drug Design; Humans; Molecular Sequence Data; Peptides, Cyclic; Structure-Activity Relationship	1998
Risks of unregulated use of alpha-melanocyte-stimulating hormone analogues: a review. International journal of dermatology, 2017, Volume: 56, Issue:10 Topics: alpha-MSH; Dermatologic Agents; Drug Compounding; Humans; Peptides, Cyclic; Risk Factors; Self Medication	2017

Other Studies

16 other study(ies) available for melanotan-ii and msh, 4-nle-7-phe-alpha-

Article	Year
Biological and conformational examination of stereochemical modifications using the template melanotropin peptide, Ac-Nle-c[Asp-His-Phe-Arg-Trp-Ala-Lys]-NH2, on human melanocortin receptors. Journal of medicinal chemistry, 1997, May-23, Volume: 40, Issue:11 Topics: Amino Acid Sequence; Chromatography, High Pressure Liquid; Cyclic AMP; Cyclization; Humans; Melanocyte-Stimulating Hormones; Peptide Fragments; Protein Conformation; Receptors, Corticotropin; Receptors, Melanocortin; Second Messenger Systems; Spectrometry, Mass, Fast Atom Bombardment; Structure-Activity Relationship; Templates, Genetic; Thermodynamics	1997
beta-Methylation of the Phe7 and Trp9 melanotropin side chain pharmacophores affects ligand-receptor interactions and prolonged biological activity. Journal of medicinal chemistry, 1997, Aug-15, Volume: 40, Issue:17 Topics: Animals; Humans; Ligands; Lizards; Melanocyte-Stimulating Hormones; Methylation; Models, Chemical; Models, Molecular; Phenylalanine; Rana pipiens; Receptors, Pituitary Hormone; Stereoisomerism; Structure-Activity Relationship; Tryptophan	1997
Structure-activity relationships of the melanocortin tetrapeptide Ac-His-DPhe-Arg-Trp-NH(2) at the mouse melanocortin receptors: part 2 modifications at the Phe position. Journal of medicinal chemistry, 2002, Jul-04, Volume: 45, Issue:14 Topics: Amino Acid Substitution; Animals; Cell Line; Humans; Mice; Oligopeptides; Phenylalanine; Receptor, Melanocortin, Type 3; Receptor, Melanocortin, Type 4; Receptors, Corticotropin; Receptors, Melanocortin; Receptors, Peptide; Structure-Activity Relationship	2002
Structure-activity relationships of the melanocortin tetrapeptide Ac-His-D-Phe-Arg-Trp-NH2 at the mouse melanocortin receptors. 4. Modifications at the Trp position. Journal of medicinal chemistry, 2002, Dec-19, Volume: 45, Issue:26 Topics: Amino Acid Substitution; Animals; Ligands; Melanocyte-Stimulating Hormones; Mice; Oligopeptides; Receptor, Melanocortin, Type 3; Receptors, Corticotropin; Receptors, Melanocortin; Structure-Activity Relationship; Tryptophan	2002
Peptide science: exploring the use of chemical principles and interdisciplinary collaboration for understanding life processes. Journal of medicinal chemistry, 2003, Sep-25, Volume: 46, Issue:20 Topics: Animals; Chemistry Techniques, Analytical; Chemistry, Physical; Drug Design; Genomics; Humans; Models, Molecular; Peptides; Protein Binding; Protein Conformation; Proteomics	2003
Stereochemical studies of the monocyclic agouti-related protein (103-122) Arg-Phe-Phe residues: conversion of a melanocortin-4 receptor antagonist into an agonist and results in the discovery of a potent and selective melanocortin-1 agonist. Journal of medicinal chemistry, 2004, Dec-30, Volume: 47, Issue:27 Topics: Agouti-Related Protein; Amino Acid Sequence; Animals; Cells, Cultured; Humans; Intercellular Signaling Peptides and Proteins; Mice; Models, Molecular; Molecular Sequence Data; Protein Conformation; Proteins; Receptor, Melanocortin, Type 1; Receptor, Melanocortin, Type 4	2004
Structure-activity relationships of the unique and potent agouti-related protein (AGRP)-melanocortin chimeric Tyr-c[beta-Asp-His-DPhe-Arg-Trp-Asn-Ala-Phe-Dpr]-Tyr-NH2 peptide template. Journal of medicinal chemistry, 2005, Apr-21, Volume: 48, Issue:8 Topics: Agouti-Related Protein; alpha-MSH; Animals; Binding, Competitive; Cell Line; Drug Design; Humans; Intercellular Signaling Peptides and Proteins; Magnetic Resonance Spectroscopy; Mice; Models, Molecular; Oligopeptides; Peptides, Cyclic; Protein Structure, Secondary; Proteins; Receptor, Melanocortin, Type 3; Receptor, Melanocortin, Type 4; Receptors, Melanocortin; Structure-Activity Relationship	2005
Backbone cyclic peptidomimetic melanocortin-4 receptor agonist as a novel orally administrated drug lead for treating obesity. Journal of medicinal chemistry, 2008, Feb-28, Volume: 51, Issue:4 Topics: Administration, Oral; Animals; Anti-Obesity Agents; Biological Availability; Brain; Cell Line; Humans; Injections, Intravenous; Intestinal Absorption; Ligands; Magnetic Resonance Spectroscopy; Male; Mice; Molecular Mimicry; Peptides, Cyclic; Rats; Rats, Wistar; Receptor, Melanocortin, Type 4; Structure-Activity Relationship; Tissue Distribution	2008
1,4-disubstituted-[1,2,3]triazolyl-containing analogues of MT-II: design, synthesis, conformational analysis, and biological activity. Journal of medicinal chemistry, 2014, Nov-26, Volume: 57, Issue:22 Topics: Azides; Chemistry, Pharmaceutical; Copper; Drug Design; HEK293 Cells; Humans; Lactams; Ligands; Linear Models; Magnetic Resonance Spectroscopy; Metallothionein; Molecular Conformation; Peptides; Receptors, Melanocortin; Structure-Activity Relationship; Triazoles	2014
Click-Chemistry-Mediated Synthesis of Selective Melanocortin Receptor 4 Agonists. Journal of medicinal chemistry, 2017, 11-09, Volume: 60, Issue:21 Topics: Animals; Click Chemistry; Cyclic AMP; Drug Evaluation, Preclinical; Humans; Peptides, Cyclic; Receptor, Melanocortin, Type 4; Structure-Activity Relationship	2017
Use of melanotan I and II in the general population. BMJ (Clinical research ed.), 2009, Feb-17, Volume: 338 Topics: alpha-MSH; Humans; Male; Nonprescription Drugs; Penile Erection; Peptides, Cyclic; Substance-Related Disorders; Suntan	2009
Melanocortin-4 receptor activation inhibits c-Jun N-terminal kinase activity and promotes insulin signaling. Peptides, 2009, Volume: 30, Issue:6 Topics: alpha-MSH; Animals; Cell Line; Dose-Response Relationship, Drug; Humans; Hypothalamus; Insulin; Insulin Receptor Substrate Proteins; JNK Mitogen-Activated Protein Kinases; Peptides, Cyclic; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Receptor, Melanocortin, Type 4; Signal Transduction; Time Factors	2009
[Melanotan]. Actas dermo-sifiliograficas, 2012, Volume: 103, Issue:4 Topics: alpha-MSH; Humans; Peptides, Cyclic; Substance-Related Disorders	2012
Hemodynamic actions and mechanisms of systemically administered α-MSH analogs in mice. Peptides, 2012, Volume: 38, Issue:1 Topics: alpha-MSH; Anesthetics; Animals; Blood Pressure; Consciousness; Dose-Response Relationship, Drug; Heart Rate; Hexamethonium; Male; Melanocyte-Stimulating Hormones; Metoprolol; Mice; Mice, Inbred C57BL; Peptides, Cyclic; Receptor, Melanocortin, Type 3; Receptor, Melanocortin, Type 4; Receptors, Corticotropin	2012
Melanocortin Receptor Agonists Facilitate Oxytocin-Dependent Partner Preference Formation in the Prairie Vole. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2015, Volume: 40, Issue:8 Topics: alpha-MSH; Animals; Arginine Vasopressin; Arvicolinae; Brain; Dose-Response Relationship, Drug; Early Growth Response Protein 1; Female; Male; Oxytocin; Pair Bond; Peptides, Cyclic; Piperidines; Pyrrolidines; Receptors, Melanocortin; Receptors, Oxytocin; Sex Characteristics; Sexual Behavior, Animal; Vasotocin	2015
A glimpse into the underground market of melanotan. Dermatology online journal, 2018, May-15, Volume: 24, Issue:5 Topics: Adolescent; Adult; alpha-MSH; Beauty Culture; Drug Trafficking; Female; Humans; Hyperpigmentation; Injections, Subcutaneous; Internationality; Internet; Male; Middle Aged; Peptides, Cyclic; Skin Pigmentation; Suntan; Surveys and Questionnaires; Young Adult	2018